Taro Matsumoto Selected Research

Trichlormethiazide (Naqua)

5/2014	Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
11/2007	Losartan improves the impaired function of endothelial progenitor cells in hypertension via an antioxidant effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taro Matsumoto Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2020 - 11/2007
7	Neoplasms (Cancer) 06/2006 - 04/2002
6	Atherosclerosis 10/2017 - 06/2003
5	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2004
4	Spinal Cord Injuries (Spinal Cord Injury) 12/2021 - 01/2008
3	Stroke (Strokes) 01/2011 - 11/2007
3	Myocardial Infarction 06/2010 - 11/2006
2	Neointima 01/2022 - 11/2006
2	Glomerulonephritis 01/2022 - 04/2015
2	Inflammation (Inflammations) 01/2020 - 02/2013
2	Wounds and Injuries (Trauma) 01/2019 - 07/2018
2	Brain Injuries (Brain Injury) 01/2017 - 10/2010
2	Hypothermia 01/2017 - 01/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2016 - 02/2013
2	Spinal Cord Diseases 12/2014 - 02/2014
2	Body Weight (Weight, Body) 05/2014 - 01/2009
2	Osteoporosis 01/2014 - 08/2013
2	Ischemia 08/2009 - 02/2004
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2009 - 03/2009
2	Hyperplasia 11/2006 - 01/2002
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2006 - 03/2006
1	Stress Urinary Incontinence 04/2022
1	Furcation Defects 02/2022
1	Teratoma (Teratoid Tumor) 02/2022
1	Atrial Fibrillation 01/2022
1	Neutropenia 12/2021
1	Bronchiolitis Obliterans Syndrome 11/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2021
1	Obesity 02/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2020
1	Intervertebral Disc Degeneration 11/2017
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2017
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 12/2016
1	Hemorrhage 04/2016
1	Testicular Neoplasms (Testicular Cancer) 01/2016
1	Proteinuria 04/2015
1	Gliosis 11/2014
1	Essential Hypertension 05/2014

Drug/Important Bio-Agent (IBA)

5	erucylphosphocholineIBA 12/2016 - 01/2008
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021 - 11/2006
4	SaltsIBA 01/2020 - 11/2007
3	CytokinesIBA 12/2021 - 11/2006
3	AngiotensinsIBA 10/2013 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010 - 07/2005
3	Messenger RNA (mRNA)IBA 01/2008 - 01/2004
2	Nylons (Nylon)IBA 04/2021 - 05/2014
2	ReninIBA 01/2020 - 10/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2016 - 03/2011
2	Trichlormethiazide (Naqua)FDA Link 05/2014 - 11/2007
2	LipidsIBA 05/2014 - 03/2009
2	Losartan (Cozaar)FDA LinkGeneric 05/2014 - 11/2007
2	CholesterolIBA 02/2010 - 01/2009
2	oxidized low density lipoproteinIBA 07/2009 - 03/2009
2	EnzymesIBA 03/2006 - 06/2003
2	EndostatinsIBA 06/2003 - 04/2002
1	Matrix Metalloproteinases (MMPs)IBA 02/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 11/2021
1	Antinuclear AntibodiesIBA 11/2021
1	Streptozocin (Streptozotocin)FDA Link 04/2021
1	imidazoleIBA 04/2021
1	PyrrolesIBA 04/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Therapeutic UsesIBA 07/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Zinc Finger NucleasesIBA 01/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	SolutionsIBA 01/2019
1	Saline SolutionIBA 01/2019
1	lixisenatideIBA 10/2017
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2017
1	Fluspirilene (Imap)IBA 10/2017
1	MagnesiumIBA 12/2016
1	Taurine FDA Link 12/2016
1	LDL Receptors (LDL Receptor)IBA 04/2016
1	Interleukin-10 (Interleukin 10)IBA 04/2015
1	Interleukin-6 (Interleukin 6)IBA 04/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015
1	Small Interfering RNA (siRNA)IBA 04/2015
1	Monoclonal AntibodiesIBA 04/2015
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2014
1	Angiotensin Receptor AntagonistsIBA 05/2014

Therapy/Procedure

9	Transplantation 02/2022 - 02/2004
8	Therapeutics 04/2022 - 06/2006
5	Cell Transplantation 07/2020 - 11/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2017
2	Laminoplasty 12/2014 - 02/2014
2	Induced Hypothermia 10/2010 - 01/2008
1	Drug-Eluting Stents 01/2022
1	Intravenous Administration 04/2021
1	Autologous Transplantation 01/2019
1	Intravenous Injections 01/2017
1	Injections 12/2016
1	Orchiectomy (Orchidectomy) 01/2016
1	Drug Therapy (Chemotherapy) 01/2014